ALK: anaplastic lymphoma kinase
BPCA: Biologics Price Competition & Innovation
CDDF: Cancer Drug Development Forum
EMA: European Medicines Agency
ENCCA: European Network for Cancer Research in Children and Adolescents
FDA: Food and Drug Agency
IMI: Innovative Medicine Initiative
ITCC: Innovative Therapies for Children with Cancer
LTFU: long-term follow-up
MA: marketing authorisation
MoA: Mechanism of Action
PDCO: Paediatric Committee [of the EMA]
PIP: Paediatric Investigation Plan
PK: pharmacokinetic
PPoC: paediatric proof of concept
PREA: Pediatric Research Equity Act
PRINTO: Paediatric Rheumatology International Trials Organisation
SIOPE: European Society for Paediatric Oncology
US[A]: United States [of America]
TYA: teenagers and young adults
WG: Working Group
WR: written requests